Tequin Merits Black Box Reconsideration For Dysglycemia, Editorial Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol’s gatifloxacin is “strongly associated with subsequent hospital care for hypoglycemia and hyperglycemia,” NEJM study finds.